Navigation Links
Most embryos produced during IVF do not result in live births

Researchers at Yale School of Medicine have found that 85 percent of embryos transferred during in vitro fertilization fail to become live births, highlighting the need for improving diagnostic techniques to identify viable embryos.

Published in the August issue of Fertility and Sterility, the study reviewed seven years of U.S. statistics from all the fertility clinics that report data on reproductive techniques. Director of the Yale Fertility Center, Pasquale Patrizio, M.D., professor in the Department of Obstetrics, Gynecology & Reproductive Sciences led the project.

"Something in nature has decided that these implanted embryos are not viable," said Patrizio, who conducted the study with co-author George Kovalevsky, M.D.

"We as practitioners in the reproductive clinic are in a paradoxical situation," Patrizio added. "There is pressure to reduce multiple births, but we need to do so knowing that the majority of the embryos that are transferred do not implant. It is difficult to strike a balance between these two needs."

Patrizio said he and his fellow physicians strive to better identify the embryos with the most potential. But addressing the growing pressure to transfer fewer embryos to reduce multiple births is a difficult task unless they can come up with a method in the lab to identify the best embryos.

"Some potential methods for screening embryos include using pre-implantation genetic diagnosis and biochemical markers of embryo viability," said Patrizio. "In addition this study should also move the field toward perfecting methods of egg production."


'"/>

Source:Yale University


Page: 1

Related biology news :

1. Scientists succeed in cloning human embryos from eggs matured in the lab
2. Changes to embryos can elicit change in adult fish
3. Forsyth scientists gain greater understanding of how embryos differentiate left from right
4. How IVF could be causing genetic errors in embryos
5. Successful transplantation from pig embryos to mice
6. Researchers report technique for freezing and preserving genetically enhanced pig embryos
7. Many couples choose to donate surplus embryos for stem cell research
8. Procedure predicts embryos most likely to result in pregnancy
9. Inexpensive, mass-produced genes core of synthetic biology advances at UH
10. Living taste cells produced outside the body
11. Plant-cell-produced technologies-cutting edge approach to bringing solutions to the market
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/21/2017)... , February 21, 2017 Der ... US-Dollar wachsen. Nach einem Gespräch mit mehr als 50 Vertretern ... Hindernisse zu überwinden gilt, um diese Prognose zu realisieren. ... ... die Mobilisierung der finanziellen Mittel für die Biobank, die ...
(Date:2/10/2017)... 10, 2017 Research and Markets ... "Personalized Medicine - Scientific and Commercial Aspects" to their ... ... is integrated with therapy for selection of treatment as well ... and prevention of disease in modern medicine. Biochip/microarray technologies and ...
(Date:2/8/2017)... The biometrics market has reached a ... organizations, desires to better authenticate or identify users ... challenge questions), biometrics is quickly working its way ... is driven by use cases, though there traditionally ... uses cases, with consumer-facing use cases encompassing authentication, ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... -- Financial Highlights ... unaudited)Three Months Ended December 31,Twelve Months Ended December 31,20162015% ... $           300$   ... Product Revenue 3539(10)%9498(4)%Kuvan Net Product ... 756025%297303(2)%Vimizim Net Product Revenue ...
(Date:2/23/2017)... 2017  MIODx announced today that it has ... technologies from the University of California, San Francisco ... monitor a patient for response to immune checkpoint ... second license extends the technology with a method ... have an immune-related adverse event (IRAE) from their ...
(Date:2/23/2017)... 2017  Imanis Life Sciences announced today the ... vaccinia viruses for virotherapy research. These viruses are ... proprietary, vaccinia virus-based technology platform for research use. ... a partnership with Genelux to offer researchers, for ... use in research," said Dr. Kah Whye ...
(Date:2/23/2017)... ... 2017 , ... David Nolte, PhD accepted Purdue University’s 2016 ... Research Park of West Lafayette, Indiana. , The top commercialization award is ... success with, commercializing discoveries from Purdue research. “This award is truly an honor. ...
Breaking Biology Technology: